Condition

Waldenstrom Macroglobulinaemia (2)

Chronic Lymphocytic Leukaemia (1)

Indolent B-cell Lymphoma (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Cancer Research UK (1)

GlaxoSmithKline (1)

Collaborator

Intervention

di-b4 (1)

ofatumumab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

waldenström macroglobulinaemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Indolent B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinaemia Trial in United Kingdom (DI-B4)

Completed

Indolent B-cell Lymphoma
+2 more

DI-B4

Liverpool, United Kingdom
+4 more

Feb 1, 2018

Waldenstrom Macroglobulinaemia Trial in United States (Ofatumumab)

Completed

Waldenstrom Macroglobulinaemia

Ofatumumab

Los Angeles, California
+6 more

Apr 28, 2017